Session 5: Breaking Down Barriers that Block Quality Care (2.25 CME)
In Session 5, you will wonder why you are even watching this session. I mean, we have access to treatment on demand, everyone knows the evidence, there is ample funding for treatment, and thank goodness that everyone screens for addiction in their practice. Maybe we would need this session if there was stigma, but everyone agrees that addiction is a chronic brain disorder and are competing for treatment centers to open in their neighborhoods. Really, thank goodness that medical schools and residency programs spend a lot of time training new physicians for the complexity of this disease and how to treat it. Because of this, we have a vibrant, motivated workforce just waiting for the next addiction patient. So, I am not sure what we are going to discuss, but it would be great if we had an audience for our speakers. Anthony Campbell, RPH, DO, CDR, USPHS, R. Corey Waller, MD, MS, FACEP, DFASAM, and Chideha M. Ohouha MD, MPHbring their years of experience and expertise to deliver an exceptional presentation covering the following: The Federal Policy Response to Removing Barriers, If Getting into the US Was Like Getting into Addiction Treatment We Wouldn't Need a Wall, Buprenorphine Prescribing: Getting to Yes, and Audience Discussion with Panelists.